NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL COA(HMG-COA) REDUCTASE INHIBITOR

摘要

A pharmaceutical composition for inhibiting the activity of 3-hydroxy-3- methylglutaryl CoA(HMG-CoA) reductase in mammals comprises an effective amount of naringin or naringenin as an active ingredient together with a pharmaceutically acceptable carrier, and a food or beverage composition for inhibiting the 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase activity in mammals comprises an effective amount of naringin or naringenin.